![](/img/cover-not-exists.png)
Outcome Prediction to Erlotinib in Gastroesophageal Adenocarcinomas: Can We Improve Epidermal Growth Factor Receptor and Phospho-AKT Testing?
Personeni, N.Volume:
25
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2006.09.8137
Date:
January, 2007
File:
PDF, 54 KB
english, 2007